Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 684-691

  Kinsley, Brendan T ^a   Simonson, Donald C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN RELEASE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; FEMALE; GLUCOSE HOMEOSTASIS; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN; MALE; METYRAPONE; NOREPINEPHRINE; PITUITARY GLAND;

EID: 0030059485     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.684     Document Type: Article

References (67)

1. Diabetes Control and Complications Trial Research Group. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin dependent diabetes mellitus. N Engl J Med. 324:977-986.
2. Reichard P, Nilsson B-Y, Rosenqvist U. 1993 The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 329:304-309.
3. Diabetes Control and Complications Trial Research Group. 1991 Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med. 90:450-459.
4. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. 1983 Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 308:485-491.
5. Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. 1985 Intensive insulin therapy reduces the counterregulatory hormone responses to hypoglycemia in patients with type 1 diabetes. Ann Intern Med. 103:184-190.
6. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. 1987 Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med. 316:1376-1383.
7. Bolli GB, De Feo P, De Cosmo S, et al. 1984 A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes mellitus. Diabetes. 33:732-737.
8. Heller SR, Herbert M, Macdonald IA, Tattersall RB. 1987 Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet. 2:359-363.
9. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. 1988 Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes. 37:901-907.
10. Mokan M, Mitrakou A, Veneman T, et al. 1994 Hypoglycemia unawareness in IDDM. Diabetes Care. 17:1397-1403.
11. Hepburn DA, Patrick AW, Brash HM, Thompson I, Frier BM. 1991 Hypoglycaemia unawareness in type 1 diabetes; a lower plasma glucose is required to stimulate sympatho-adrenal activation. Diabetic Med. 8:934-945.
12. Ryder REJ, Owens DR, Hayes TM, Ghatei M, Bloom SR. 1990 Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relationship with diabetic autonomic neuropathy. Br Med J. 301:783-787.
13. Clarke WL, Gonder-Fredrick LA, Richards LE, Cryer PE. 1991 Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control. Diabetes. 40:680-685.
14. Schwartz NS, Clutter WE, Shah SD, Cryer PE. 1987 Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest. 79:777-781.
15. Mitrakou A, Ryan C, Veneman T, et al. 1991 Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260:E67-E74.
16. Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM. 1990 Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabetic Med. 7:711-717.
17. Maran A, Taylor J, McDonald IA, Amiel SA. 1992 Evidence of reversibility of defective counterregulation in a patient with insulinoma. Diabetic Med. 9:765-768.
18. Mitrakou A, Fanelli C, Veneman T, et al. 1993 Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med. 329:834-839.
19. Davis MR, Shamoon H. 1991 Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma. J Clin Endocrinol Metab. 72:788-792.
20. Widom B, Simonson DC. 1992 Intermittent hypoglycemia impairs glucose counterregulation. Diabetes. 41:1597-1602.
21. Heller SR, Cryer PE. 1991 Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in non-diabetic humans. Diabetes. 40:223-226.
22. Davis MR, Shamoon H. 1991 Counterregulatory adaptation to hypoglycemia in normal humans. J Clin Endocrinol Metab. 73:995-1001.
23. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. 1993 Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes. 42:1233-1237.
24. Davis MR, Mellman M, Shamoon H. 1992 Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes. 41: 1335-1340.
25. Lingenfelser T, Renn W, Sommerwerck U, et al. 1993 Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin induced hypoglycemia in IDDM patients. Diabetes. 42:610-618.
26. Dagogo-Jack S, Craft S, Cryer P. 1993 Hypoglycemia-associated autonomic failure in insulin dependent diabetes. J Clin Invest. 91:819-828.
27. Fanelli CG, Epifano L, Ramboti AM, et al. 1993 Meticulous prevention of hypoglycemia normalizes glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes. 42: 1683-1689.
28. Davis M, Mellman M, Friedman S, Chang CJ, Shamoon H. 1994 Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. Am J Med. 97:535-541.
29. Dagogo-Jack S, Rattarasarn C, Cryer PE. 1994 Reversal of hypoglycemic unawareness, but not defective glucose counterregulation in IDDM. Diabetes. 43:1426-1434.
30. Lingenfelser T, Buettner T, Uhl H, et al. 1994 Recovery of hypoglycaemia-associated compromised cerebral function after short interval of euglycaemia in insulin dependent diabetic patients. Electroencephalogr Clin Neurophysiol. 92:196-203.
31. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. 1994 Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet. 344:283-287.
32. Fanelli C, Pampanelli S, Epifano L, et al. 1994 Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia following institution of rational intensive insulin therapy in IDDM. Diabetologia. 34:1265-1276.
33. McCall AL, Fixman LB, Fleming N, et al. 1986 Chronic hypoglycemia increases brain glucose transport. Am J Physiol 251:E442-E447.
34. Pelligrino DA, Segil LJ, Albrecht RF. 1990 Brain glucose utilization and transport and cortical function in chronic vs acute hypoglycemia. Am J Physiol 259:E729-E735.
35. Pardridge WM, Triguero D, Farrell CR, et al. 1990 Downregulation of blood-brain glucose transporter in experimental diabetes. Diabetes. 39:1040-1044.
36. Boyle PJ, Nagy RJ, O'Connor A, Kempers SF, Yeo RA, Qualls C. 1994 Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA. 91:9352-9356.
37. Frier BM, Fisher BM, Gray CE, Beastall GH. 1988 Counterregulatory hormonal responses to hypoglycemia in type 1 (insulin dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion. Diabetologia. 31:421-429.
38. Ewing DJ, Clarke BF. 1982 Diagnosis and management of diabetic autonomic neuropathy. Br Med J. 285:916-918.
39. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M. 1976 Effects of arterial vs venous sampling on analysis of glucose kinetics in man. J Appl Physiol. 41:565-573.
40. DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223.
41. Spiger M, Jubiz W, Meikle AW, West CD, Tyler FH. 1971 Single-dose metyrapone test. Arch Intern Med. 125:472-474.
42. Rosenfield RL, Heike J, Lucky AW. 1985 Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin. J Clin Endocrinol Metab. 60:585-589.
43. Soeldner JS, Slone D. 1965 Critical variables in the radio-immunoassay of serum insulin using the double antibody technique. Diabetes. 14:771-779.
44. 1 by agar gel electrophoresis. Clin Chem. 26:1598-1602.
45. Tasseron SJ, Fiolet JW, Wilebrands JW. 1980 Evaluation of radioenzymatic kit for determination of plasma catecholamines. Clin Chem. 26:120-122.
46. Boden G, Soeldner JS. 1967 A sensitive double antibody radioimmunoassay for human growth hormone. Diabetologia. 3:413-421.
47. Foster LB, Dunn RT. 1974 Single antibody technique for radioimmunoassay of cortisol in unextracted serum or plasma. Clin Chem. 20:365-368.
48. Maroulis GB, Manlimos FS, Garza R, Abraham GE. 1976 Serum cortisol and 11-desoxycortisol levels in hirsute postmenopausal women. Obstet Gynecol. 48:388-391.
49. White A, Smith H, Hadley M, Dobson SH, Ratcliffe JG. 1987 Clinical evaluation of a two site immunoradiometric assay for adrenocorticotrophin in unextracted human plasma using monoclonal antibodies. Clin Endocrinol (Oxf). 26:41-52.
50. Kinsley BT, Widom B, Simonson DC. 1995 Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM: effect of glycemic control. Diabetes Care. 18:17-26.
51. Gallucci WT, Kamilaris TA, Roy A, Roy M, Gold PW, Chrousos GP. 1990 Glycemic control and hypothalamic-pituitary-adrenal axis in patients with type 1 diabetes mellitus. Diabetes. 39(Suppl 1):103A.
52. Kinsley BT, Widom B, Utzschneider K, Simonson DC. 1994 Stimulus specificity of defects in counterregulatory hormone secretion in insulin dependent diabetes mellitus. Effect of glycemic control. J Clin Endocrinol Metab. 79:1383-1389.
53. Karteszi M, Dallman MF, Makara GB, Stark E. 1982 Regulation of adrenal-cortical response to insulin-induced hypoglycemia. Endocrinology. 111:535-541.
54. Suda T, Tozawa F, Yamada M, et al. 1988 Insulin-induced hypoglycemia increases corticotropin releasing factor messenger ribonucleic acid levels in rat hypothalamus. Endocrinology. 123:1371-75.
55. Frizell RT, Jones EM, Davis SN, et al. 1993 Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes. 42:1253-1261.
56. Caraty A, Grino M, Locatelli A, et al. 1990 Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams. J Clin Invest. 85:1716-1721.
57. DeCherney GS, DeBold C, Jackson RV, et al. 1987 Effect of ovine corticotropin-releasing hormone administered during insulin hypoglycemia on plasma adrenocorticotropin and cortisol. J Clin Endocrinol Metab. 64:1211-1218.
58. Baylis PH, Zerbe RL, Robertson GL. 1981 Arginine vasopressin response to insulin-induced hypoglycemia in man. J Clin Endocrinol Metab. 53:935-940.
59. Miles-Fisher B, Baylis P, Thornton S, Frier BM. 1989 Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type 1 (insulin dependent) diabetes. J Clin Endocrinol Metab. 68:688-692.
60. Thompson CJ, Thow J, Jones IR, Baylis PH. 1989 Vasopressin secretion during insulin-induced hypoglycemia: exaggerated response in people with type 1 diabetes. Diabetic Med. 6:158-163.
61. Nakao K, Nakai Y, Jingami H, Oki S, Junichi F, Imura H. 1979 Substantial rise of plasma β-endorphin levels after insulin-induced hypoglycemia in human subjects. J Clin Endocrinol Metab. 49:838-841.
62. Caprio S, Gerety G, Tamborlane VW, et al. 1991 Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects. Am J Physiol 260:E852-E858.
63. Axelrod J, Reisine TD. 1984 Stress hormones: their interaction and regulation. Science. 224:452-459.
64. Wurtman RJ, Axelrod J. 1965 Adrenaline synthesis: control by the pituitary gland and adrenal glucocorticoids. Science. 150:1464-1465.
65. Wurtman RJ, Axelrod J. 1966 Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J Biol Chem. 241:2301-2305.
66. Sandler R, Proudfoot GR. 1985 Isolated ACTH deficiency contributing to frequent hypoglycemia in type 1 diabetes. Diabetes Care. 8:302-305.
67. Rudman D, Moffitt SD, Fernhoff PM, Blachston RD, Faraj BA. 1981 Epinephrine deficiency in hypocorticotropic hypopituitary children. J Clin Endocrinol Metab. 53:722-729.